Genetic predisposition to left ventricular dysfunction: A multigenic and multi-analytical approach

Gene

Volumn 546, Issue 2, 2014, Pages 309-317

  Mishra, Avshesh ^a   Srivastava, Anshika ^a   Mittal, Tulika ^a   Garg, Naveen ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Genetic predisposition; Higher order gene gene interaction; Left ventricular ejection fraction (LVEF); LVD; MDR

Indexed keywords

ALDOSTERONE SYNTHASE; ANGIOTENSIN 1 RECEPTOR; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MATRILYSIN; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; MULTIFACTOR DIMENSIONALITY REDUCTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ACCURACY; ADULT; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; GENE ORDER;

GENETIC PREDISPOSITION; HIGHER ORDER GENE-GENE INTERACTION; LEFT VENTRICULAR EJECTION FRACTION (LVEF); LVD; MDR;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84903536009     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.05.060     Document Type: Article

References (39)

1. Alvarez R., Reguero J.R., Batalla A., Iglesias-Cubero G., Cortina A., Alvarez V., Coto E. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc. Res. 1998, 40:375-379.
2. Canavy I., Henry M., Morange P.E., Tiret L., Poirier O., Ebagosti A., Bory M., Juhan-Vague I. Genetic polymorphisms and coronary artery disease in the south of France. Thromb. Haemost. 2000, 83:212-216.
3. Cassar A., Holmes D.R., Rihal C.S., Gersh B.J. Chronic coronary artery disease: diagnosis and management. Mayo Clin. Proc. 2009, 84:1130-1146.
4. Cherkassky V., Ma Y. Another look at statistical learning theory and regularization. Neural Netw. 2009, 22:958-969.
5. de Haan H.G., Bezemer I.D., Doggen C.J., Le Cessie S., Reitsma P.H., Arellano A.R., Tong C.H., Devlin J.J., Bare L.A., Rosendaal F.R., Vossen C.Y. Multiple SNP testing improves risk prediction of first venous thrombosis. Blood 2012, 120:656-663.
6. Deschamps A.M., Spinale F.G. Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation. Cardiovasc. Res. 2006, 69:666-676.
7. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 1986, 57:450-458.
8. Frantz S., Fraccarollo D., Wagner H., Behr T.M., Jung P., Angermann C.E., Ertl G., Bauersachs J. Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. Cardiovasc. Res. 2003, 57:749-756.
9. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16:225-260.
10. Gibbons G.H., Liew C.C., Goodarzi M.O., Rotter J.I., Hsueh W.A., Siragy H.M., Pratt R., Dzau V.J. Genetic markers: progress and potential for cardiovascular disease. Circulation 2004, 109:IV47-IV58.
11. Gunja-Smith Z., Morales A.R., Romanelli R., Woessner J.F. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links. Am. J. Pathol. 1996, 148:1639-1648.
12. Hanatani A., Yoshiyama M., Kim S., Omura T., Toda I., Akioka K., Teragaki M., Takeuchi K., Iwao H., Takeda T. Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J. Mol. Cell. Cardiol. 1995, 27:1905-1914.
13. Johnson R., McNutt P., MacMahon S., Robson R. Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clin. Chem. 1997, 43:2183-2184.
14. Kathiresan S., Melander O., Anevski D., Guiducci C., Burtt N.P., Roos C., Hirschhorn J.N., Berglund G., Hedblad B., Groop L., Altshuler D.M., Newton-Cheh C., Orho-Melander M. Polymorphisms associated with cholesterol and risk of cardiovascular events. N. Engl. J. Med. 2008, 358:1240-1249.
15. Kuusisto J., Karja V., Sipola P., Kholova I., Peuhkurinen K., Jaaskelainen P., Naukkarinen A., Yla-Herttuala S., Punnonen K., Laakso M. Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy. Heart 2012, 98:1007-1013.
16. Li J., Schwimmbeck P.L., Tschope C., Leschka S., Husmann L., Rutschow S., Reichenbach F., Noutsias M., Kobalz U., Poller W., Spillmann F., Zeichhardt H., Schultheiss H.P., Pauschinger M. Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction. Cardiovasc. Res. 2002, 56:235-247.
17. Lunetta K.L., Hayward L.B., Segal J., Van Eerdewegh P. Screening large-scale association study data: exploiting interactions using random forests. BMC Genet. 2004, 5:32.
18. Meigs J.B., Shrader P., Sullivan L.M., McAteer J.B., Fox C.S., Dupuis J., Manning A.K., Florez J.C., Wilson P.W., D'Agostino R.B., Cupples L.A. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N. Engl. J. Med. 2008, 359:2208-2219.
19. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
20. Mishra A., Srivastava A., Mittal T., Garg N., Mittal B. Association of matrix metalloproteinases (MMP2, MMP7 and MMP9) genetic variants with left ventricular dysfunction in coronary artery disease patients. Clin. Chim. Acta 2012, 413:1668-1674.
21. Mishra A., Srivastava A., Mittal T., Garg N., Mittal B. Impact of renin-angiotensin-aldosterone system gene polymorphisms on left ventricular dysfunction in coronary artery disease patients. Dis. Markers 2012, 32:33-41.
22. Mishra A., Srivastava A., Mittal T., Garg N., Mittal B. Role of inflammatory gene polymorphisms in left ventricular dysfunction (LVD) susceptibility in coronary artery disease (CAD) patients. Cytokine 2013, 61:856-861.
23. Morgan A.R., Zhang B., Tapper W., Collins A., Ye S. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J. Mol. Med. (Berl.) 2003, 81:321-326.
24. Nanni S., Melandri G., Hanemaaijer R., Cervi V., Tomasi L., Altimari A., Van Lent N., Tricoci P., Bacchi L., Branzi A. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms. Transl. Res. 2007, 149:137-144.
25. Phillips M.I., Kagiyama S. Angiotensin II as a pro-inflammatory mediator. Curr. Opin. Investig. Drugs 2002, 3:569-577.
26. Rickham P.P. Human experimentation. Code of ethics of the World Medical Association. Declaration of Helsinki. Br. Med. J. 1964, 2:177.
27. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., Moore J.H. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 2001, 69:138-147.
28. Rutschow S., Li J., Schultheiss H.P., Pauschinger M. Myocardial proteases and matrix remodeling in inflammatory heart disease. Cardiovasc. Res. 2006, 69:646-656.
29. Santos D.G., Resende M.F., Mill J.G., Mansur A.J., Krieger J.E., Pereira A.C. Nuclear factor (NF) kappaB polymorphism is associated with heart function in patients with heart failure. BMC Med. Genet. 2010, 11:89.
30. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J. Am. Soc. Echocardiogr. 1989, 2:358-367.
31. Sethupathy P., Borel C., Gagnebin M., Grant G.R., Deutsch S., Elton T.S., Hatzigeorgiou A.G., Antonarakis S.E. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am. J. Hum. Genet. 2007, 81:405-413.
32. Shapira I., Isakov A., Yakirevich V., Topilsky M. Long-term results of coronary artery bypass surgery in patients with severely depressed left ventricular function. Chest 1995, 108:1546-1550.
33. Spinale F.G., Coker M.L., Thomas C.V., Walker J.D., Mukherjee R., Hebbar L. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ. Res. 1998, 82:482-495.
34. Srivastava K., Srivastava A., Kumar A., Mittal B. Gallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes. PLoS One 2011, 6:e16449.
35. Sutton M.G., Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000, 101:2981-2988.
36. Tiret L., Bonnardeaux A., Poirier O., Ricard S., Marques-Vidal P., Evans A., Arveiler D., Luc G., Kee F., Ducimetiere P., et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994, 344:910-913.
37. Triposkiadis F., Karayannis G., Giamouzis G., Skoularigis J., Louridas G., Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J. Am. Coll. Cardiol. 2009, 54:1747-1762.
38. Wang L., M.Y., Xie X., et al. Association of MMP-9 gene polymorphisms with acute coronary syndrome in the Uygur population of China. World J. Emerg. Med. 2011, 2:104-110.
39. Weber K.T., Brilla C.G., Janicki J.S. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc. Res. 1993, 27:341-348.